Horizon Pharma Public Limited Company (HZNP) was a big mover last session, as the company saw its shares rise nearly 11% on the day amid huge volumes.
Seattle Genetics, Inc.'s (SGEN) supplemental Biologics License Application for Adcetris in patients with cutaneous T-cell lymphoma has been accepted by the FDA and granted priority review.
Novo Nordisk (NVO) pipeline candidate shows superior glucose control and weight loss in study in diabetes patients compared with Eli Lilly and Co's Trulicity (dulaglutide).
Spectrum Pharmaceuticals, Inc. (SPPI) initiated the registrational phase III study of qapzola in patients with non-muscle invasive bladder cancer (NMIBC) as per the FDA's requirement.
Shire plc (SHPG) submitted a Marketing Authorization Application (MAA) for lifitegrast for the treatment of dry eye disease in Europe.
Alexion Pharm (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $135.29 to a high of $137.61. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of...
MiMedx Group (MDXG) was a big mover last session, as the company saw its rise over 6% on the day amid huge volumes.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patents No. 9,732,149; 9,718,880; and 9,725,504, which...
SmarTrend identified an Uptrend for Alexion Pharm (NASDAQ:ALXN) on June 12th, 2017 at $106.88. In approximately 2 months, Alexion Pharm has returned 25.77% as of today's recent price of $134.42.
Biotech companies, Regeneron (REGN) and Alexion, both topped estimates in Q2 and raised their outlook. But, which stock is better-positioned for the second half of the year?
Editas Medicine, Inc. (EDIT) moved big moved last session, as its shares rose over 11% on the day.
With generic drugmakers like Teva (TEVA) under pressure, here is a look at four drug stocks that look well-positioned.
Investors need to pay close attention to Alexion Pharmaceuticals (ALXN) stock based on the movements in the options market lately.
Puma Biotechnology (PBYI) reported narrower-than-expected loss in Q2. Shares were down in after-hours trading.
Geron Corporation (GERN) reported narrower-than-expected loss in Q2 while sales missed estimates. Shares were up in after-hours trading.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Sema4 today announced a strategic partnership to leverage their shared experience in data science and systems biology to accelerate rare disease...
With Bayer (BAYRY) reporting mixed results in the second quarter and lowering its outlook, here is a look at 3 drug stocks which look well positioned.
Dynavax Technologies Corporation (DVAX) was a big mover last session, as the company saw its shares rise over 11% on the day.
BUYINS.NET / www.buyins.net is monitoring Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) in real time and just received an alert that ALXN is crossing above its primary SqueezeTrigger Price, the price that...
SmarTrend identified an Uptrend for Alexion Pharm (NASDAQ:ALXN) on June 12th, 2017 at $106.88. In approximately 2 months, Alexion Pharm has returned 29.43% as of today's recent price of $138.33.